Regional Scientific Director, Mid-Atlantic Region
Intellia Therapeutics, Inc.
10 hours ago
On-site
Virginia, United States
$216,000 - $264,000 USD yearly
Medical Affairs
Regional Scientific Director (Associate Director level) — Medical/Customer-facing role supporting Intellia’s CRISPR-based gene editing programs (nex-z and lonvo-z).
Responsibilities
- Engage KOLs across ATTR amyloidosis and HAE; educate on CRISPR gene editing platform, MoA, and clinical data.
- Understand patient journey at key centers; identify site capabilities/preferences.
- Develop individualized scientific engagement plans aligned with scientific narrative and medical strategy.
- Identify external insights/knowledge gaps via listening; report timely insights through CRM.
- Attend Medical Congresses for KOL engagement, booth staffing, session coverage, insights gathering, and reporting.
- Deliver institutional presentations on Intellia scientific evidence as appropriate.
- Provide scientific support for Phase 3 trials during site start-up, activation, and recruitment.
- Establish, cultivate, and maintain scientific relationships with Investigators and study site teams.
- Identify and help resolve barriers to site activation and/or patient recruitment; escalate feedback/concerns to clinical teams.
- Develop strong understanding of clinical practice and referral pathways for gene editing therapies.
- Ensure compliance and scientific integrity; complete trainings and adhere to policies.
Qualifications
- Demonstrated success in a highly matrixed, cross-functional environment.
- Ability to assess priorities (urgency, risk) and provide recommendations to leadership.
- Ability to anticipate change and adapt to business needs.
- Self-starter with collaborative, results-oriented approach.
- Strong organization and multitasking with accuracy and attention to detail.
- Excellent presentation, communication, and project management skills (in-person, digital, email, phone, etc.).
- Ability to communicate complex scientific/medical information to internal and external stakeholders.
- Established track record of influential oral presentations.
- Ability to complete required training, documentation, expense reporting, and administrative tasks.
- Travel 50–70% (including overnight stays); manage territory from home-based office.
- Proficiency with Excel, Word, PowerPoint, Outlook, and Zoom.
- Valid driver’s license.
- Doctorate/terminal degree (Pharm.D., Ph.D., M.D., or D.O.).
- 3+ years industry/related experience.
- Extensive clinical trial experience, including Phase 3.
- Prior pharmaceutical MSL/RSD experience; strong scientific exchange and clinical trial execution in a regulated/compliance environment.
Preferred
- Therapeutic knowledge in allergy/immunology/HAE, cardiology (ATTR-CM/ATTR-PN), or genetic medicine.
- New product launch experience.
Location/Territory
- Mid-Atlantic: Maryland, DC, North Carolina, South Carolina, Virginia, Delaware, Charleston.
Benefits/Compensation (as stated)
- Base salary expected: $216,000–$264,000 USD/year.
- Performance-based annual cash bonus; new hire equity grant; eligibility for annual equity awards.
Application instructions
- Applications accepted on a rolling basis until the position is filled.
Responsibilities
- Engage KOLs across ATTR amyloidosis and HAE; educate on CRISPR gene editing platform, MoA, and clinical data.
- Understand patient journey at key centers; identify site capabilities/preferences.
- Develop individualized scientific engagement plans aligned with scientific narrative and medical strategy.
- Identify external insights/knowledge gaps via listening; report timely insights through CRM.
- Attend Medical Congresses for KOL engagement, booth staffing, session coverage, insights gathering, and reporting.
- Deliver institutional presentations on Intellia scientific evidence as appropriate.
- Provide scientific support for Phase 3 trials during site start-up, activation, and recruitment.
- Establish, cultivate, and maintain scientific relationships with Investigators and study site teams.
- Identify and help resolve barriers to site activation and/or patient recruitment; escalate feedback/concerns to clinical teams.
- Develop strong understanding of clinical practice and referral pathways for gene editing therapies.
- Ensure compliance and scientific integrity; complete trainings and adhere to policies.
Qualifications
- Demonstrated success in a highly matrixed, cross-functional environment.
- Ability to assess priorities (urgency, risk) and provide recommendations to leadership.
- Ability to anticipate change and adapt to business needs.
- Self-starter with collaborative, results-oriented approach.
- Strong organization and multitasking with accuracy and attention to detail.
- Excellent presentation, communication, and project management skills (in-person, digital, email, phone, etc.).
- Ability to communicate complex scientific/medical information to internal and external stakeholders.
- Established track record of influential oral presentations.
- Ability to complete required training, documentation, expense reporting, and administrative tasks.
- Travel 50–70% (including overnight stays); manage territory from home-based office.
- Proficiency with Excel, Word, PowerPoint, Outlook, and Zoom.
- Valid driver’s license.
- Doctorate/terminal degree (Pharm.D., Ph.D., M.D., or D.O.).
- 3+ years industry/related experience.
- Extensive clinical trial experience, including Phase 3.
- Prior pharmaceutical MSL/RSD experience; strong scientific exchange and clinical trial execution in a regulated/compliance environment.
Preferred
- Therapeutic knowledge in allergy/immunology/HAE, cardiology (ATTR-CM/ATTR-PN), or genetic medicine.
- New product launch experience.
Location/Territory
- Mid-Atlantic: Maryland, DC, North Carolina, South Carolina, Virginia, Delaware, Charleston.
Benefits/Compensation (as stated)
- Base salary expected: $216,000–$264,000 USD/year.
- Performance-based annual cash bonus; new hire equity grant; eligibility for annual equity awards.
Application instructions
- Applications accepted on a rolling basis until the position is filled.